Institute for Pediatric Regenerative Medicine, University of California Davis School of Medicine, Shriners Hospitals for Children, Sacramento, California, USA.
Glia. 2023 Feb;71(2):143-154. doi: 10.1002/glia.24249. Epub 2022 Jul 16.
Clinical and basic neuroscience research is greatly benefited from the identification and characterization of lineage specific and developmental stage-specific markers. In the glial research community, histological markers that specifically label newly differentiated premyelinating oligodendrocytes are still scarce. Premyelinating oligodendrocyte markers, especially those of nuclear localization, enable researchers to easily quantify the rate of oligodendrocyte generation regardless of developmental ages. We propose that the transcription factor 7-like 2 (TCF7l2, mouse gene symbol Tcf7l2) is a useful nuclear marker that specifically labels newly generated premyelinating oligodendrocytes and promotes oligodendroglial lineage progression. Here, we highlight the controversial research history of TCF7l2 expression and function in oligodendroglial field and discuss previous experimental data justifying TCF7l2 as a specific nuclear marker for premyelinating oligodendrocytes during developmental myelination and remyelination. We conclude that TCF7l2 can be used alone or combined with pan-oligodendroglial lineage markers to identify newly differentiated or newly regenerated oligodendrocytes and quantify the rate of oligodendrocyte generation.
临床和基础神经科学研究受益于谱系特异性和发育阶段特异性标记物的鉴定和特征描述。在神经胶质研究领域,特异性标记新分化的少突胶质前体细胞的组织学标记仍然很少。少突胶质前体细胞标记物,特别是那些核定位的标记物,使研究人员能够轻松地量化少突胶质细胞生成的速度,而与发育年龄无关。我们提出转录因子 7 样 2(TCF7l2,小鼠基因符号 Tcf7l2)是一种有用的核标记物,它特异性地标记新生成的少突胶质前体细胞,并促进少突胶质谱系的进展。在这里,我们强调了 TCF7l2 在少突胶质细胞领域的表达和功能的有争议的研究历史,并讨论了以前的实验数据,这些数据证明 TCF7l2 是发育性髓鞘形成和髓鞘再生过程中少突胶质前体细胞的特异性核标记物。我们的结论是,TCF7l2 可以单独使用或与泛少突胶质细胞谱系标记物结合使用,以识别新分化或新再生的少突胶质细胞,并量化少突胶质细胞的生成速度。